Viewing Study NCT03284658

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:12 AM
Ignite Modification Date: 2026-05-11 @ 3:10 PM
Study NCT ID: NCT03284658
Status: WITHDRAWN
Last Update Posted: 2023-02-13
First Post: 2017-09-13
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Biomarker for the Early Diagnosis and Monitoring in Tyrosinemia Type 1 (BioTyrosin)
Sponsor: CENTOGENE GmbH Rostock
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tyrosinosis View
None Hepatorenal Tyrosinemia View
None Fumarylacetoacetase Deficiency View
None Fah Deficiency View
None Metabolic Disorders View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tyrosinemia Type 1 View
None Biomarker View